MedTrace Logo

PTLD: Multicentric Retrospective Study

NCT06422715 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2025-12-02

No results posted yet for this study

Summary

This is a multicentric observational retrospective cohort study of patients with histological diagnosis of PTLD.

The aim of the study is to analyze the clinical features and survival of patients who received a PTLD diagnosis with the target to assess a survival outcome, to obtain an epidemiologic and clinical characterization of the subpopulations affected by PTLD, to recognize unfavorable properties, to report the current treatment strategies, to provide rationale for the design of a prospective registry in order to develop future novel treatments.

Conditions

  • PTLD

Sponsors & Collaborators

  • Pierre Fabre Pharma AG

    collaborator INDUSTRY

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Federica Cavallo, MD · Ematologia Universitaria - A.O.U. Citta della Salute e della Scienza di Torino

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-30
Primary Completion
2025-08-12
Completion
2026-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06422715 on ClinicalTrials.gov